Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 3Leukoplakia, Oral 2Insulin Resistance 2Diabetes Mellitus 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Metabolic Syndrome 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1Glucose Intolerance 1Diabetes Mellitus, Type 2 1Carotid Intimal Medial Thickness 1 1Carcinoma, Squamous Cell 1

Interventions

Resistance Training 2Pioglitazone 2Nutrition Assessment 2Methods 2Metformin 2otelixizumab 1Verapamil 1Therapeutics 1Tablets 1Secretin 1Risk Assessment 1Observation 1Jogging 1Fatty Acids, Omega-3 1Exercise 1Educational Status 1Desvenlafaxine Succinate 1Ascorbic Acid 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Diabetes Mellitus × Pioglitazone × Clear all
NCT01637935 2018-03-07

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

Takeda

Completed
193,099 enrolled 15 charts
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus

NCT02958956 2018-03-07

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

Takeda

Completed
236,507 enrolled 13 charts

Diabetes Mellitus, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡